Evidence map›Paper›PMID 38424230›Full record

ArticleEMBO reports2024

mTert induction in p21-positive cells counteracts capillary rarefaction and pulmonary emphysema.

Larissa Lipskaia, Marielle Breau, Christelle Cayrou, Dmitri Churikov, Laura Braud, Juliette Jacquet, Emmanuelle Born, Charles Fouillade, Sandra Curras-Alonso, Serge Bauwens and 12 more

Open access · diamondAbstract read
In one paragraph

Article in EMBO reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Angiogenesis in Lung Regeneration and Aging.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Microvascular Health as a Key Determinant of Organismal Aging.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 3 countries.

Larissa Lipskaia *Institute for Lung Health, Justus Liebig University, Giessen, Germany.
Marielle Breau *Marseille Cancer Research Centre (CRCM), U1068 INSERM, UMR7258 CNRS, UM105 Aix-Marseille University, Institut Paoli-Calmettes, Ligue Nationale Contre le Cancer (Equipe labellisée), Team Telomeres and Chromatin, Marseille, France.
Christelle CayrouMarseille Cancer Research Centre (CRCM), U1068 INSERM, UMR7258 CNRS, UM105 Aix-Marseille University, Institut Paoli-Calmettes, Ligue Nationale Contre le Cancer (Equipe labellisée), Team Telomeres and Chromatin, Marseille, France.ORCID 0000-0002-6910-8023
Dmitri ChurikovMarseille Cancer Research Centre (CRCM), U1068 INSERM, UMR7258 CNRS, UM105 Aix-Marseille University, Institut Paoli-Calmettes, Ligue Nationale Contre le Cancer (Equipe labellisée), Team Telomeres and Chromatin, Marseille, France.ORCID 0000-0003-1127-8852
Laura BraudMarseille Cancer Research Centre (CRCM), U1068 INSERM, UMR7258 CNRS, UM105 Aix-Marseille University, Institut Paoli-Calmettes, Ligue Nationale Contre le Cancer (Equipe labellisée), Team Telomeres and Chromatin, Marseille, France.ORCID 0000-0002-8958-3817
Juliette JacquetInstitute for Lung Health, Justus Liebig University, Giessen, Germany.
Emmanuelle BornInstitute for Lung Health, Justus Liebig University, Giessen, Germany.ORCID 0000-0002-0557-3727
Charles FouilladeInstitut Curie, Inserm U1021, CNRS UMR 3347, University Paris-Saclay, PSL Research University, Orsay, France.ORCID 0000-0003-2692-5645
Sandra Curras-AlonsoInstitut Curie, PSL Research University, CNRS UMR3244, Sorbonne Université, Telomeres and Cancer, 75005, Paris, France.
Serge BauwensUniversité Côte d'Azur, CNRS, Inserm, IRCAN, Faculty of Medicine, Nice, France.
Frederic JourquinMarseille Cancer Research Centre (CRCM), U1068 INSERM, UMR7258 CNRS, UM105 Aix-Marseille University, Institut Paoli-Calmettes, Ligue Nationale Contre le Cancer (Equipe labellisée), Team Telomeres and Chromatin, Marseille, France.ORCID 0000-0001-6848-6973
Frederic FioreCentre d'Immunophénomique, Aix Marseille Université, INSERM, CNRS UMR, Marseille, France.ORCID 0000-0001-7955-6594
Rémy CastellanoMarseille Cancer Research Centre (CRCM), TrGET Preclinical Platform, Institut Paoli-Calmettes, Inserm, CNRS, Aix Marseille Université, Marseille, France.ORCID 0000-0002-0152-985X
Emmanuelle JosselinMarseille Cancer Research Centre (CRCM), TrGET Preclinical Platform, Institut Paoli-Calmettes, Inserm, CNRS, Aix Marseille Université, Marseille, France.
Carlota Sánchez-FerrerCentro Nacional de Investigaciones Cardiovasculares Carlos III, 28029, Madrid, Spain.
Giovanna GiovinazzoCentro Nacional de Investigaciones Cardiovasculares Carlos III, 28029, Madrid, Spain.
Christophe LachaudMarseille Cancer Research Centre (CRCM), U1068 INSERM, UMR7258 CNRS, UM105 Aix-Marseille University, Institut Paoli-Calmettes, Team DNA Interstrand Crosslink Lesions and Blood Disorders, Marseille, France.ORCID 0000-0003-2762-1619
Eric GilsonUniversité Côte d'Azur, CNRS, Inserm, IRCAN, Faculty of Medicine, Nice, France.ORCID 0000-0001-5738-6723
Ignacio FloresCentro Nacional de Investigaciones Cardiovasculares Carlos III, 28029, Madrid, Spain.
Arturo Londono-VallejoInstitut Curie, PSL Research University, CNRS UMR3244, Sorbonne Université, Telomeres and Cancer, 75005, Paris, France.ORCID 0000-0003-3535-7563
Serge AdnotInstitute for Lung Health, Justus Liebig University, Giessen, Germany. Serge.Adnot@innere.med.uni-giessen.de.ORCID 0000-0001-5666-3063
Vincent GéliMarseille Cancer Research Centre (CRCM), U1068 INSERM, UMR7258 CNRS, UM105 Aix-Marseille University, Institut Paoli-Calmettes, Ligue Nationale Contre le Cancer (Equipe labellisée), Team Telomeres and Chromatin, Marseille, France. vincent.geli@inserm.fr.ORCID 0000-0002-4103-7462
Centre National de la Recherche Scientifique · FRSpanish National Centre for Cardiovascular Research · ESInserm · FRJustus-Liebig-Universität Gießen · DE

Funding

CARCINOGEN-INDUCED GENETIC ALTERATIONS IN ANIMAL CELLSF32CA007524 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MONTELONE, BETH A · 1985 to 1985
–
MARIHUANA EFFECTS ON TESTIS AND BEHAVIOR IN MICER01DA003875 · NIDA · SOUTHERN ILLINOIS UNIVERSITY CARBONDALE · PI BARTKE, ANDRZEJ · 1985 to 1988
–
Canceropôle PACA (Canceropole PACA) Projet EmergentComunidad de Madrid (Community of Madrid) S2017/BMD-3875Fondation ARC pour la Recherche sur le Cancer (ARC) Projet ARCInstitut National de la Santé et de la Recherche Médicale (Inserm) AGEMEDInstitut National Du Cancer (INCa) PLBIO2019Ligue Contre le Cancer (French League Against Cancer) Comité Paris RS21/75-24Ligue Contre le Cancer (French League Against Cancer) Equipe LabelliséeMinisterio de Ciencia e Innovación (MCIN) PID2019-110339RB-I00PHENOMIN (French National Infrastructure for Mouse Phenogenomics) ANR10-INBS-07
6 · The paper itself

Abstract

Lung diseases develop when telomeres shorten beyond a critical point. We constructed a mouse model in which the catalytic subunit of telomerase (mTert), or its catalytically inactive form (mTert

Indexed as

EmphysemaMicrovascular RarefactionPulmonary EmphysemaTelomeraseAnimalsMiceTelomere ShorteningTelomeraseCapillary DensityEmphysemap21SenescenceTelomerase

Identifiers

PMID38424230
PMCPMC10933469
OpenAlexW4392298390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.